Insomnia drug approved in Europe

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
daridorexant, Insomnia, benzodiazepines, orexin

Studies have shown that this drug improves sleep and daytime performance in people with insomnia, without causing a sedative effect the next day, as occurs with benzodiazepines

The Hospital CLÍNIC-IDIBAPS is leading a study to identify people who may develop Parkinson’s disease

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
“Healthy Brain Aging” (HeBA), dopamine

Researchers from the Hospital Clínic-IDIBAPS are leading a study to obtain information on 10,000 healthy people who do not have Parkinson's disease, in order to identify those individuals at high ris...

IDIBAPS participates in the development of a new chronic lymphocytic leukemia solution with SOPHiA GENETICS and Diagnóstica Longwood

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
chronic lymphocytic leukemia, IgCaller Software, SOPHiA GENETICS, Diagnóstica Longwood, TP53

The IgCaller Software is a bioinformatics tool capable of detecting the genomic alterations that make different types of leukemia, such as chronic lymphocytic leukemia (CLL) or lymphomas, more aggress...

Long-term effects of antidepressants

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
antidepressants, pharmacotherapy

A study with the participation of millions of people has concluded that antidepressants do not improve the long-term quality of life of patients. Dr Vieta, head of the Clínic's Psychiatry Unit, expla...

A new treatment is effective for advanced HER2-low breast cancer

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
HER2, breast cancer, trastuzumab deruxtecan

Researchers from the Hospital Clínic-IDIBAPS, the Catalan Institute of Oncology (ICO)-IDIBELL and the Vall d’Hebron Institute of Oncology (VHIO), which forms part of the Vall d’Hebron Campus, par...

How have treatments for hepatocellular carcinoma improved?

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
hepatocellular carcinoma, atezolizumab, bevacizumab

Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they describe the molecular alterations observed in th...

New study shows genes can predict response to arthritis treatment and paves the way for future drug development

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
arthritis treatment, refractory disease, rheumatoid arthritis, tocilizumab, rituximab

New research coordinated from Queen Mary University of London, and with the participation of Juan de Dios Cañete, Julio Ramírez and Raquel Celis, researchers of the IDIBAPS Inflammatory joint diseas...

IDIBAPS and EUROIMMUN sign a new agreement on research into neuronal inflammatory diseases

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
IDIBAPS and EUROIMMUN, autoantigens, diagnostic tests, neuronal inflammatory diseases

The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labordiagnostika AG (EUROIMMUN) have signed a new collaboration agr...

Dr. Joan Bartra: “Although we are getting better at controlling allergic disease, we are still a long way from finding a cure”

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
respiratory allergy, dust mites, Changes in the pollination rate, IgE antibodies

Respiratory allergy affects around 25% of the general population, especially in spring, at the height of the pollen season. We talk to Dr. Joan Bartra about the most common allergies and why they occu...

What research is being done in inflammatory bowel disease?

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
Inflammatory bowel disease, Crohn disease and ulcerative coliti, single-cell RNA sequencing

Understanding the mechanisms involved in ulcerative colitis and Crohn disease and identifying new therapeutic targets and markers for response to treatment are the main objectives of the researchers. ...

Laboratory-generated mini-kidneys help understand the link between diabetes and COVID-19 disease

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
diabetes and COVID-19 disease, mini-kidneys, ACE2 receptor

Researchers from Hospital Clínic-IDIBAPS have participated in an international collaboration led by IBEC in which they have generated human mini-kidneys that simulate the kidney of a person with diab...

Seven out of every ten patients with non-alcoholic fatty liver disease feel stigmatized

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
non-alcoholic fatty liver, NAFLD, Stereotypes, discrimination, embarrassment, and social isolation, Stigmatization

The study, in which Hospital Clínic-IDIBAPS researchers have participated, shows that the perception of this stigma is associated with a deterioration in the quality of life of people who suffer from...